![4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine Structure](https://www.chemicalbook.com/CAS/20180808/GIF/1394033-54-5.gif)
4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine
- Product Name4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine
- CAS1394033-54-5
- CBNumberCB63039872
- MFC19H17F3N8
- MW414.39
- MDL NumberMFCD28411615
- MOL File1394033-54-5.mol
- MSDS FileSDS
Chemical Properties
| Density | 1.57±0.1 g/cm3(Predicted) |
| storage temp. | room temp |
| solubility | DMSO: 10 mM |
| pka | 3.88±0.30(Predicted) |
| form | powder |
| color | white to beige |
| FDA UNII | 5L84K4IEN9 |
| UNSPSC Code | 41106305 |
| NACRES | NA.77 |
Safety
| Symbol(GHS) |
|
|||||||||
| Signal word | Danger | |||||||||
| Hazard statements | H301-H315-H319-H335 | |||||||||
| Precautionary statements | P301+P310+P330-P302+P352-P305+P351+P338 | |||||||||
| RIDADR | UN 2811 6.1 / PGIII | |||||||||
| NFPA 704: |
|
